GSK wins U.S. nod for two-drug HIV combination

GSK wins U.S. nod for two-drug HIV combination

Source: 
Yahoo/Reuters
News Tags: 
snippet: 

GlaxoSmithKline Plc's two-drug treatment for HIV infections won U.S. market approval on Monday, boosting the British drugmaker's growth prospects against competitor Gilead Sciences Inc.